Advertisement
Screener

4D Molecular Therapeutics, Inc. (FDMT) Other

4D Molecular Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-08-13: Form 10-Q; Item Shares outstanding CommonStock as of 2026-08-10; As filed 55,244,211.
  • 2026-08-13: Form 10-Q; Item Shares outstanding PreFundedWarrants as of 2026-08-10; As filed 16,935,665.
  • 2026-05-07: Form 10-Q; Item Shares outstanding CommonStock as of 2026-05-04; As filed 52,276,254.
  • 2026-05-07: Form 10-Q; Item Shares outstanding PreFundedWarrants as of 2026-05-04; As filed 16,935,665.
FiledFormItemAs filed
2026-08-1310-QShares outstanding CommonStock as of 2026-08-1055,244,211
2026-08-1310-QShares outstanding PreFundedWarrants as of 2026-08-1016,935,665
2026-05-0710-QShares outstanding CommonStock as of 2026-05-0452,276,254
2026-05-0710-QShares outstanding PreFundedWarrants as of 2026-05-0416,935,665
2026-03-1810-KShares outstanding CommonStock as of 2026-03-1651,051,487
2026-03-1810-KShares outstanding PreFundedWarrants as of 2026-03-1616,935,665
2025-11-1010-QShares outstanding CommonStock as of 2025-11-0757,135,075
2025-11-1010-QShares outstanding PreFundedWarrants as of 2025-11-0710,513,949
2025-08-1110-QShares outstanding CommonStock as of 2025-08-0446,702,467
2025-08-1110-QShares outstanding PreFundedWarrants as of 2025-08-049,385,000
2025-08-1110-QSmaller reporting companyNo
2025-05-0810-QShares outstanding CommonStock as of 2025-05-0546,324,642
2025-05-0810-QShares outstanding PreFundedWarrants as of 2025-05-059,385,000
2025-05-0810-QSmaller reporting companyNo
2025-02-2810-KShares outstanding CommonStock as of 2025-02-2646,302,407
2025-02-2810-KShares outstanding PreFundedWarrants as of 2025-02-263,075,000
2025-02-2810-KShares outstanding PrefundedWarrantsOne as of 2025-02-266,310,000
2024-11-1310-QShares outstanding CommonStock as of 2024-11-1246,227,709
2024-11-1310-QShares outstanding PreFundedWarrants as of 2024-11-123,583,476
2024-11-1310-QShares outstanding PrefundedWarrantsOne as of 2024-11-125,775,000
2024-11-1310-QEmerging growth companyYes
2024-08-0810-QShares outstanding CommonStock as of 2024-08-0251,969,590
2024-08-0810-QShares outstanding PreFundedWarrants as of 2024-08-023,583,476
2024-08-0810-QEmerging growth companyYes
2024-05-0910-QShares outstanding CommonStock as of 2024-05-0351,703,412
2024-05-0910-QShares outstanding PreFundedWarrants as of 2024-05-033,583,476
2024-05-0910-QEmerging growth companyYes
2024-02-2910-KEmerging growth companyYes
2023-11-0910-QEmerging growth companyYes
2023-08-0910-QEmerging growth companyYes
2023-05-1110-QEmerging growth companyYes
2023-03-1510-KEmerging growth companyYes
2022-11-0810-QEmerging growth companyYes
2022-08-1110-QEmerging growth companyYes
2022-05-1210-QEmerging growth companyYes
2022-03-2810-KEmerging growth companyYes
2021-11-1010-QEmerging growth companyYes
2021-08-1210-QEmerging growth companyYes
2021-05-1310-QEmerging growth companyYes
2021-03-2510-KEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Entera Bio Ltd. (ENTX)$0.485B